Patents by Inventor Christopher Mark HILL

Christopher Mark HILL has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240071365
    Abstract: Disclosed are example embodiments of systems, method, and devices for generating audio assets. The example method includes receiving an input including at least one of audio, text, video, Java Script Object Notation (JSON), Extensible Markup Language (XML), Really Simple Syndication (RSS). The example method includes receiving configuration inputs including at least one of configure language, gender, and persona. The example method includes preparing for processing based on the at least one of configure language, gender, and persona. The example method includes processing the input based on the configuration inputs, the processing including at least one of transcribing, translating, brand safety, enrichment, generating custom Speech Synthesis Markup Language (SSML), and including generating an audio clip. The example method includes delivering the audio clip.
    Type: Application
    Filed: November 7, 2022
    Publication date: February 29, 2024
    Inventors: Chad Edward Steelberg, Ryan Scott Steelberg, Sean Patrick King, Corey Denard Hill, Christopher Mark Doe
  • Publication number: 20210122820
    Abstract: Provided are methods for clinical treatment of hematological malignancies, such as relapsed or refractory chronic lymphocytic leukemia or lymphoma using an anti-LAG-3 antibody. Particular malignancies include, e.g., chronic lymphocytic leukemia (CLL), Hodgkin lymphoma (HL), or non-Hodgkin lymphoma (NHL).
    Type: Application
    Filed: September 9, 2020
    Publication date: April 29, 2021
    Inventors: Andres A. GUTIERREZ, Joseph GROSSO, Christopher Mark HILL, Mark J. SELBY, Katherine E. LEWIS
  • Patent number: 10753265
    Abstract: Described herein is an exhaust air pollution elimination device configured for attachment to an exhaust pipe of an internal combustion engine for removing pollutants from an exhaust flow. The device comprising multiple stages configured to both power the operation of the device and treat the exhaust flow. The device configured for installation in line with existing exhaust piping and through a pair of connecting rings. The multiple stages of the device including an electrostatic precipitator, a thermoelectric generator, an electromagnetic induction device, and a second container including a UV light source and micro fibrous mesh containing titanium dioxide.
    Type: Grant
    Filed: May 16, 2019
    Date of Patent: August 25, 2020
    Inventor: Christopher Mark Hill
  • Publication number: 20200131973
    Abstract: Described herein is an exhaust air pollution elimination device configured for attachment to an exhaust pipe of an internal combustion engine for removing pollutants from an exhaust flow. The device comprising multiple stages configured to both power the operation of the device and treat the exhaust flow. The device configured for installation in line with existing exhaust piping and through a pair of connecting rings. The multiple stages of the device including an electrostatic precipitator, a thermoelectric generator, an electromagnetic induction device, and a second container including a UV light source and micro fibrous mesh containing titanium dioxide.
    Type: Application
    Filed: May 16, 2019
    Publication date: April 30, 2020
    Inventor: CHRISTOPHER MARK HILL
  • Publication number: 20180244773
    Abstract: Provided are methods for clinical treatment of hematological malignancies, such as relapsed or refractory chronic lymphocytic leukemia or lymphoma using an anti-LAG-3 antibody. Particular malignancies include, e.g., chronic lymphocytic leulcemia (CLL), Hodgkin lymphoma (HL), or non-Hodgkin lymphoma (NHL).
    Type: Application
    Filed: February 9, 2018
    Publication date: August 30, 2018
    Inventors: Andres A. GUTIERREZ, Joseph GROSSO, Christopher Mark HILL, Mark J. SELBY, Katherine E. LEWIS
  • Publication number: 20160326248
    Abstract: Provided are methods for clinical treatment of hematological malignancies, such as relapsed or refractory chronic lymphocytic leukemia or lymphoma using an anti-LAG-3 antibody. Particular malignancies include, e.g., chronic lymphocytic leukemia (CLL), Hodgkin lymphoma (HL), or non-Hodgkin lymphoma (NHL).
    Type: Application
    Filed: January 26, 2015
    Publication date: November 10, 2016
    Applicant: BRISTOL-MYERS SQUIBB COMPANY
    Inventors: Andres A. GUTIERREZ, Joseph GROSSO, Christopher Mark HILL, Mark J. SELBY, Katherine E. LEWIS